RecruitingNCT05651113

The Experience of Screening for SCID

Exploring Parents' and Health Professionals' Experiences of Screening for Severe Combined Immunodeficiency


Sponsor

King's College London

Enrollment

90 participants

Start Date

Nov 9, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This project will evaluate the impact of including Severe Combined Immunodeficiency into the newborn bloodspot screening panel. It will recruit parents and health professionals primarily from the sites where this new form of screening is being trialled well as additional sites where clinicians will be involved in the care of these babies and comparator groups are needed. The proposed work will consist of two work packages. The first, a mixed-methods study conducted with families from the point of screening information being returned through to the child's fifth birthday. The second, a qualitative interview study conducted with health professionals during the clinical evaluation phase of the national pilot programme.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying SCID Screening for people with severe combined immunodeficiency. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSCID Screening

The addition of newborn bloodspot screening for severe combined immunodeficiency


Locations(1)

King's College London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05651113


Related Trials